Zhonghong Pulin (China) Performance

300981 Stock   13.86  0.73  5.00%   
On a scale of 0 to 100, Zhonghong Pulin holds a performance score of 11. The firm maintains a market beta of -0.72, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Zhonghong Pulin are expected to decrease at a much lower rate. During the bear market, Zhonghong Pulin is likely to outperform the market. Please check Zhonghong Pulin's information ratio, total risk alpha, and the relationship between the coefficient of variation and jensen alpha , to make a quick decision on whether Zhonghong Pulin's historical returns will revert.

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Zhonghong Pulin Medical are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Zhonghong Pulin sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield
0.0343
Payout Ratio
7.4922
Last Split Factor
1.3:1
Forward Dividend Rate
0.5
Ex Dividend Date
2024-06-27
1
Zhonghong Pulin Medical Products Co., Ltd.s Price Is Right But Growth Is Lacking After Shares Rocket 29 percent - Simply Wall St
11/19/2024
Begin Period Cash Flow451 M
  

Zhonghong Pulin Relative Risk vs. Return Landscape

If you would invest  974.00  in Zhonghong Pulin Medical on September 19, 2024 and sell it today you would earn a total of  412.00  from holding Zhonghong Pulin Medical or generate 42.3% return on investment over 90 days. Zhonghong Pulin Medical is generating 0.7193% of daily returns and assumes 5.0061% volatility on return distribution over the 90 days horizon. Simply put, 44% of stocks are less volatile than Zhonghong, and 86% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon Zhonghong Pulin is expected to generate 6.9 times more return on investment than the market. However, the company is 6.9 times more volatile than its market benchmark. It trades about 0.14 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of risk.

Zhonghong Pulin Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Zhonghong Pulin's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Zhonghong Pulin Medical, and traders can use it to determine the average amount a Zhonghong Pulin's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1437

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns300981
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 5.01
  actual daily
44
56% of assets are more volatile

Expected Return

 0.72
  actual daily
14
86% of assets have higher returns

Risk-Adjusted Return

 0.14
  actual daily
11
89% of assets perform better
Based on monthly moving average Zhonghong Pulin is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zhonghong Pulin by adding it to a well-diversified portfolio.

Zhonghong Pulin Fundamentals Growth

Zhonghong Stock prices reflect investors' perceptions of the future prospects and financial health of Zhonghong Pulin, and Zhonghong Pulin fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Zhonghong Stock performance.

About Zhonghong Pulin Performance

By analyzing Zhonghong Pulin's fundamental ratios, stakeholders can gain valuable insights into Zhonghong Pulin's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Zhonghong Pulin has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Zhonghong Pulin has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Zhonghong Pulin is entity of China. It is traded as Stock on SHE exchange.

Things to note about Zhonghong Pulin Medical performance evaluation

Checking the ongoing alerts about Zhonghong Pulin for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Zhonghong Pulin Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Zhonghong Pulin is way too risky over 90 days horizon
Zhonghong Pulin appears to be risky and price may revert if volatility continues
The company reported the revenue of 2.11 B. Net Loss for the year was (130.87 M) with profit before overhead, payroll, taxes, and interest of 152.48 M.
About 73.0% of the company shares are owned by insiders or employees
Evaluating Zhonghong Pulin's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Zhonghong Pulin's stock performance include:
  • Analyzing Zhonghong Pulin's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Zhonghong Pulin's stock is overvalued or undervalued compared to its peers.
  • Examining Zhonghong Pulin's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Zhonghong Pulin's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Zhonghong Pulin's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Zhonghong Pulin's stock. These opinions can provide insight into Zhonghong Pulin's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Zhonghong Pulin's stock performance is not an exact science, and many factors can impact Zhonghong Pulin's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Zhonghong Stock analysis

When running Zhonghong Pulin's price analysis, check to measure Zhonghong Pulin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zhonghong Pulin is operating at the current time. Most of Zhonghong Pulin's value examination focuses on studying past and present price action to predict the probability of Zhonghong Pulin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zhonghong Pulin's price. Additionally, you may evaluate how the addition of Zhonghong Pulin to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Valuation
Check real value of public entities based on technical and fundamental data